Stifel cuts ServiceNow stock price target on growth concerns By Investing.com

ServiceNow shares fell about 12% after hours as investors focused on softer second-quarter guidance for current remaining performance obligations organic growth of around 17%, down from 20% in Q1. The company still beat CRPO by roughly 100 bps and raised its 2026 AI target to $1.5 billion from $1 billion, but management also flagged near-term dilution from Armis and back-end-loaded growth. Stifel cut its price target to $120 from $135 and removed the stock from its Select List, citing uncertainty around the timing of AI-driven growth acceleration.

Analysis

The market is reacting to a classic “good quarter, worse guide” setup, but the bigger issue is not the near-term growth print—it’s the implied slope of monetization for AI. When revenue is subscription-recognized while demand is consumption-led, the company can win the logo and still miss the timeline, which creates repeated compression risk as investors keep pulling forward the inflection that accounting will delay. That makes every incremental capex or AI investment announcement more dangerous in the near term because it raises the hurdle rate for margin expansion before the revenue bridge is visible.

The competitive read-through is more interesting than the selloff itself: the company is effectively telling the market that AI spend is real, but the revenue contribution will arrive in chunks later, which favors vendors with faster payback cycles and clearer usage-based monetization. That should help adjacent AI workflow and infrastructure names with shorter conversion loops, while pressuring enterprise software peers that are also asking investors to underwrite back-end-loaded AI benefits. In other words, the market may start re-rating not just this name, but the entire “AI attached to recurring software” cohort toward lower near-term credibility until a few quarters of acceleration actually show up.

The contrarian view is that the move may be too punitive if investors are extrapolating a single quarter into a multi-quarter deterioration. If the current guide is merely conservative and the AI pipeline is real, the stock can squeeze hard on any evidence that the third-quarter lull is less severe than feared, because positioning is likely weak after a 45% drawdown. But the burden of proof is now on management: without a visible step-up in organic billings and a cleaner margin bridge, the stock remains a momentum trap rather than a value opportunity.

Key Decisions for Investors

• Avoid adding to NOW into the next print; use a 4-8 week wait-and-see window until management proves the AI monetization bridge is shortening. Risk/reward is poor if organic growth stays mid-to-high teens while margins lag.
• For higher-conviction expressiveness, buy NOW put spreads or use a bearish call spread into the next 1-2 earnings events. The setup is for repeated guide pressure if the market continues to discount back-end-loaded AI revenue.
• If already long NOW, hedge with a short pair against a faster-monetizing enterprise AI/software beneficiary over the next 1-2 quarters. The trade works if investors rotate toward names with clearer consumption capture and less revenue-recognition lag.
• Set a tactical buyback trigger only on confirmation of a third-quarter reacceleration in current RPO/organic billings, not on headline AI commentary. Until then, treat rallies as sellable given the weak positioning and margin overhang.
• Watch for a short-covering squeeze if management produces any upside surprise on margin expansion or an earlier-than-expected AI conversion cadence; that would be the highest-risk scenario for shorts, but it likely requires evidence, not narrative.